Sangamo Therapeutics Inc
NASDAQ: SGMO
$0.96
+$0.06 (+6.7%)
Closing Price on September 20, 2024
SGMO Articles
These are some of the top pre-market analyst upgrades and positive calls from Wall Street this Thursday morning: AEterna Zentaris (AEZS) Raised to Outperform at RBC. Akamai Tech (AKAM) Raised to Buy...
Published:
Last Updated:
Focus Media (FMCN) is getting crushed this morning after posted bad numbers. Details.. Sangamo Biosciences (SGMO) ran into drug trial troubles and will trade way down. Optimer Pharmaceuticals (OPTR)...
Published:
Last Updated:
These are the top early bird analyst downgrades we are seeing with more than two hours to the open on this Tuesday morning: Alcoa (NYSE: AA) Cut to Market Perform at FBR. Allianz (NYSE: AZ) Cut to...
Published:
Last Updated:
(ALTH) Allos Therapeutics trading down 20% after its Phase III study of Efaproxyn failed to meet primary endpoint of improvement in overall survival.(BAY) Bayer raised guidance on Schering...
Published: